Ononin

Ononin is an isoflavone glycoside — the 7-O-glucoside of formononetin — found primarily in leguminous plants such as red clover and astragalus. It exerts its primary effects by modulating estrogen receptor signaling and suppressing NF-κB-driven neuroinflammation and oxidative stress pathways.

Origin & History

Ononin (formononetin-7-O-β-D-glucoside) is a natural isoflavone glycoside primarily sourced from the roots, stems, and rhizomes of plants in the Fabaceae family, particularly Astragalus membranaceus (Astragali Radix) and Sophora subprostrata. It is typically extracted using solvent-based methods such as ethanol or methanol maceration, followed by chromatographic purification (PMID: 38773908).

Historical & Cultural Context

Ononin is derived from Astragali Radix (Huang Qi), a cornerstone herb in Traditional Chinese Medicine used for over 2,000 years to tonify qi, boost immunity, and treat fatigue and inflammation. While ononin itself is not explicitly named in classical texts like Shennong Bencao Jing (ca. 200 CE), it contributes to the herb's documented anti-inflammatory and adaptogenic effects in TCM formulas.

Health Benefits

• May support cognitive function and reduce postoperative cognitive decline - shown in mouse models to reduce hippocampal inflammation and oxidative stress (PMID: 41024503) - preliminary evidence only
• May protect joint cartilage and reduce arthritis symptoms - rat studies showed improved cartilage morphology and reduced inflammatory cytokines in osteoarthritis models (PMID: PMC11527302) - preliminary evidence only
• May provide cardioprotective effects against drug-induced toxicity - rat studies demonstrated restored heart function and reduced ER stress in doxorubicin-induced cardiotoxicity (PMID: 35914558) - preliminary evidence only
• May possess anti-cancer properties - mouse and cell studies showed reduced tumor growth and enhanced apoptosis in lung cancer models (PMID: 36605098) - preliminary evidence only
• May offer neuroprotective and anti-inflammatory effects - multiple animal studies demonstrated reduced neuroinflammation markers and oxidative damage (PMID: 41024503, 41241051) - preliminary evidence only

How It Works

Ononin acts as a phytoestrogen by binding weakly to estrogen receptors (ERα and ERβ), with preferential affinity for ERβ, which modulates downstream anti-inflammatory gene expression. It suppresses the NF-κB signaling pathway, reducing pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 in hippocampal and synovial tissue. Additionally, ononin upregulates Nrf2-mediated antioxidant defenses, increasing superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity to mitigate oxidative damage.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on ononin. All available evidence comes from preclinical studies in animal models (mice and rats) and in vitro cell lines, including studies on postoperative cognitive dysfunction (PMID: 41024503), osteoarthritis (PMID: PMC11527302), and cardiotoxicity (PMID: 35914558).

Clinical Summary

Current evidence for ononin is derived entirely from preclinical animal and cell models, with no completed human clinical trials published to date. A mouse model study (PMID: 41024503) demonstrated that ononin administration reduced postoperative cognitive decline by attenuating hippocampal neuroinflammation and oxidative stress markers, though sample sizes and dosing protocols are limited in translational relevance. Separate rat arthritis studies reported improved cartilage integrity and reduced synovial inflammation scores, suggesting potential chondroprotective effects. The overall evidence base is preliminary and requires well-designed randomized controlled trials in humans before any efficacy conclusions can be drawn.

Nutritional Profile

Ononin is an isoflavone O-glucoside (specifically formononetin-7-O-glucoside) with a molecular weight of approximately 430.43 g/mol. It is not a macronutrient source and contains no meaningful calories, fiber, protein, or conventional vitamins/minerals. As a bioactive phytochemical, it functions primarily as an isoflavonoid compound found in plants such as Astragalus membranaceus, red clover (Trifolium pratense), and Ononis spinosa. It is a glycosylated precursor to formononetin, with gut microbiota-mediated hydrolysis converting it to the aglycone formononetin and subsequently to equol in some individuals. Bioavailability is dependent on intestinal glucosidase activity and microbiome composition; the deglycosylated form (formononetin) is more readily absorbed than the intact glucoside. It exhibits antioxidant activity linked to its phenolic hydroxyl groups and acts on NF-κB and Nrf2 signaling pathways. Concentrations in plant sources vary widely; standardized extracts of Astragalus may contain ononin in the range of 0.01–0.5% dry weight depending on species and extraction method.

Preparation & Dosage

No human clinical dosages have been established. Animal studies used: intraperitoneal 30 mg/kg in mice, intra-articular 100-400 μg/kg weekly in rats, and intragastric 30-60 mg/kg in rats. Human dosing cannot be extrapolated from animal studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ononin pairs well with Astragalus polysaccharides (APS), as both are co-occurring compounds in Astragalus root that work through complementary immunomodulatory and anti-inflammatory pathways — APS activates macrophage-mediated immunity while ononin suppresses NF-κB-driven neuroinflammation and synovial inflammation, producing additive anti-inflammatory effects. Quercetin is a synergistic partner due to shared Nrf2 pathway activation and antioxidant upregulation (particularly HO-1 and SOD induction), which could amplify ononin's observed reduction of hippocampal oxidative stress beyond either compound alone. Curcumin complements ononin in joint health applications, as curcumin inhibits COX-2 and TNF-α at the protein level while ononin appears to reduce upstream cytokine gene expression (IL-1β, IL-6) in cartilage models, creating a multi-target approach to osteoarthritis inflammation; piperine (from black pepper) further enhances this stack by inhibiting glucuronidation, improving bioavailability of both isoflavones and curcumin.

Safety & Interactions

No human safety or toxicology trials for isolated ononin have been published, making a definitive side effect profile impossible to establish at this time. As a phytoestrogen, ononin may theoretically interact with hormone-sensitive conditions such as estrogen receptor-positive breast cancer, endometriosis, or uterine fibroids, and caution is warranted. Potential interactions with anticoagulants, hormone replacement therapies, or selective estrogen receptor modulators (SERMs) like tamoxifen cannot be ruled out given the estrogenic mechanism. Pregnant and breastfeeding individuals should avoid supplementation until safety data in these populations are available.